RAM
WST icon

Riggs Asset Management’s West Pharmaceutical WST Stock Holding History

Riggs Asset Management’s Portfolio WST Stock Details WST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-2
Closed -$438 – 873
2025
Q2 		$438 Buy
+2
New +$428 ﹤0.01% 854
2024
Q3 		– Sell
-1
Closed -$330 – 711
2024
Q2 		$330 Buy
+1
New +$353 ﹤0.01% 595

Other funds holding WST

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $64.6B AUM 18.98% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
VanEck Associates
VanEck Associates New York $164B AUM 112.45% 1-Year Est. Return
APG Asset Management
APG Asset Management Amsterdam, Netherlands $40.7B AUM 39.97% 1-Year Est. Return

Riggs Asset Management's WST Position: Q3 2025 in Review

Riggs Asset Management sold out of West Pharmaceutical (WST) in Q3 2025, closing a stake of 2 shares — an estimated $438 sold.

Riggs Asset Management first reported a position in WST in Q2 2024 and held it in 2 quarters. The position peaked at $438 in Q2 2025. 758 funds tracked by Wall St. Rank hold WST as of Q3 2025.

  • Riggs Asset Management reported no remaining West Pharmaceutical position as of Q3 2025 after selling out during the quarter.
  • Riggs Asset Management sold 2 West Pharmaceutical shares in Q3 2025, an estimated $438.
  • Riggs Asset Management first reported a position in West Pharmaceutical in Q2 2024 and held it in 2 quarters.
  • Riggs Asset Management's West Pharmaceutical position peaked at $438 in Q2 2025.
  • 758 funds tracked by Wall St. Rank held West Pharmaceutical as of Q3 2025.

Based on Riggs Asset Management's 13F filing for Q3 2025, filed 13 Nov 2025.